MolNFT v1 · #164889 · protein
Crystal structure of the omalizumab Fab LEU158PRO light chain mutant - crystal form II
6TCP: “Crystal structure of the omalizumab Fab LEU158PRO light chain mutant - crystal form II”. X-ray diffraction, 1 ligand (SO4). MolNFT v1 #164889 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6TCP
- Type
- protein
- Length
- 1,726 residues
- Chains
- 8
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Ligands
- SO4
Structure
x-ray diffraction · 6 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L, A | — | protein | 217 | — | — |
| H | — | protein | 215 | — | — |
| B | — | protein | 216 | — | — |
| C, E | — | protein | 216 | — | — |
| D | — | protein | 212 | — | — |
| F | — | protein | 217 | — | — |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 11 copies · chains L, H, A, B, C, D, E, F
- GOL · Glycerol · additive · 11 copies · chains L, H, A, B, D, E, F
- PEG · Di(hydroxyethyl)ether · additive · chains L
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 6TCP · Crystal structure of the omalizumab Fab Leu158Pro light chain mutant - crystal form II · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 6TCP · PDBe 6TCP
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.